Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2022-06-02 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, compliance with regulatory rules, and future intentions to continue the buyback. It references previous announcements and regulatory guidelines but does not contain financial statements or comprehensive financial data. The document length is short (1524 characters) and focuses on the update of share repurchase activity rather than a full financial report or earnings release. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers company buyback or sale of its own shares.
2022-06-02 Chinese
关于对下属公司对外担保的进展公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about the progress of external guarantees provided by the company and its subsidiaries. It includes specifics about guarantee contracts, amounts, counterparties, and board approvals. The content focuses on financial guarantees and related contractual details rather than financial statements or audit opinions. There is no indication that this is an annual or interim report, audit report, earnings release, or any other financial report type. It is a regulatory announcement about financing guarantees and related corporate actions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-05-31 Chinese
第八届董事会第十三次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of a board meeting resolution regarding the appointment of senior management personnel. It includes details about the meeting date, attendance, and voting results. It references a separate announcement for more details on the appointment. This fits the category of Board/Management Information (MANG), as it concerns changes in senior management. The document length is short and focused on management changes, not a full report or financial data.
2022-05-18 Chinese
关于聘任公司高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of senior management personnel at 普洛药业股份有限公司. It details the approval of appointments by the board of directors, including the names, qualifications, and backgrounds of the appointed individuals. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content focuses solely on management changes. According to the filing definitions, announcements of changes in senior management fall under 'Board/Management Information' (MANG). The document length is short and it is clearly an announcement, not a full report or certification.
2022-05-18 Chinese
独立董事关于对聘任公司高级管理人员的独立意见
Board/Management Information Classification · 100% confidence The document is a formal independent directors' opinion on the appointment of senior management personnel at 普洛药业股份有限公司. It references compliance with relevant laws and company articles, and concludes with agreement on the appointments. There is no financial data, no report or announcement of financial results, no voting results, no legal proceedings, no capital changes, and no other categories fitting financial or regulatory filings. This is a management-related announcement specifically about senior management appointments, which fits the Board/Management Information (MANG) category.
2022-05-18 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the company's first share repurchase (buyback) plan and execution details. It includes specifics about the number of shares repurchased, prices, compliance with regulatory rules, and future intentions to continue the buyback program. There are no financial statements or detailed financial performance data, nor is it a report or presentation. The content fits the definition of a Transaction in Own Shares (POS) filing, which covers company announcements about share repurchases.
2022-05-17 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.